Axillary Dissection
Axillary Dissection is a medical procedure with 7 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Prospective Evaluation of Targeted Axillary Dissection (TAD)
Feasibility of Serratus Plane Block Associated With Sedation in Axillary Dissection
Sentinel Lymph Node Biopsy in Patients With Breast Cancer After Neoadjuvant Therapy
Sentinel Node Biopsy Alone or With Axillary Dissection After Primary Chemotherapy
Preventing Seroma Formation After Stripping Saphenous Vein in Coronary Bypass
Clinical Trials (7)
Prospective Evaluation of Targeted Axillary Dissection (TAD)
Feasibility of Serratus Plane Block Associated With Sedation in Axillary Dissection
Sentinel Lymph Node Biopsy in Patients With Breast Cancer After Neoadjuvant Therapy
Sentinel Node Biopsy Alone or With Axillary Dissection After Primary Chemotherapy
Preventing Seroma Formation After Stripping Saphenous Vein in Coronary Bypass
Preventing Seroma Formation After Axillary Lymph Node Dissection for Breast Cancer by Early Vacuum Assisted Closure
Conservative Surgery With or Without Axillary Lymphnode Removal in Treating Women With T1N0 Breast Cancer
All 7 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 7